Department of Medicinal Chemistry, University of Michigan, Ann Arbor, MI, USA.
Department of Medicinal Chemistry, University of Michigan, Ann Arbor, MI, USA; Department of Pharmacology, University of Michigan, Ann Arbor, MI, USA.
Mol Cell Endocrinol. 2021 May 15;528:111261. doi: 10.1016/j.mce.2021.111261. Epub 2021 Mar 26.
Cytochrome P450 17A1 (CYP17A1) is a critical steroidogenic enzyme, essential for producing glucocorticoids and sex hormones. This review discusses the complex activity of CYP17A1, looking at its role in both the classical and backdoor steroidogenic pathways and the complex chemistry it carries out to perform both a hydroxylation reaction and a carbon-carbon cleavage, or lyase reaction. Functional and structural investigations have informed our knowledge of these two reactions. This review focuses on a few specific aspects of this discussion: the identities of reaction intermediates, the coordination of hydroxylation and lyase reactions, the effects of cytochrome b, and conformational selection. These discussions improve understanding of CYP17A1 in a physiological setting, where CYP17A1 is implicated in a variety of steroidogenic diseases. This information can be used to improve ways in which CYP17A1 can be effectively modulated to treat diseases such as prostate and breast cancer, Cushing's syndrome, and glioblastoma.
细胞色素 P450 17A1(CYP17A1)是一种关键的甾体激素合成酶,对于产生糖皮质激素和性激素至关重要。本综述讨论了 CYP17A1 的复杂活性,研究了其在经典和旁路甾体激素合成途径中的作用,以及它进行羟化反应和碳-碳裂解或裂解反应所执行的复杂化学过程。功能和结构研究为我们对这两种反应的认识提供了信息。本综述重点讨论了这一讨论的几个具体方面:反应中间体的身份、羟化和裂解反应的协调、细胞色素 b 的影响以及构象选择。这些讨论有助于在生理环境中更好地理解 CYP17A1,因为 CYP17A1 与多种甾体激素疾病有关。这些信息可用于改进有效调节 CYP17A1 的方法,以治疗前列腺癌和乳腺癌、库欣综合征和胶质母细胞瘤等疾病。